1368488
2012
1
heidelberg-university-faculty-of-medicine
50
creator
asc
year
1
233
https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22ZZW2GD62%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ahuja%20et%20al.%22%2C%22parsedDate%22%3A%222012%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAhuja%2C%20S.%20D.%2C%20Ashkin%2C%20D.%2C%20Avendano%2C%20M.%2C%20Banerjee%2C%20R.%2C%20Bauer%2C%20M.%2C%20Bayona%2C%20J.%20N.%2C%20Becerra%2C%20M.%20C.%2C%20Benedetti%2C%20A.%2C%20Burgos%2C%20M.%2C%20Centis%2C%20R.%2C%20Chan%2C%20E.%20D.%2C%20Chiang%2C%20C.-Y.%2C%20Cox%2C%20H.%2C%20D%26%23x2019%3BAmbrosio%2C%20L.%2C%20DeRiemer%2C%20K.%2C%20Dung%2C%20N.%20H.%2C%20Enarson%2C%20D.%2C%20Falzon%2C%20D.%2C%20Flanagan%2C%20K.%2C%20Flood%2C%20J.%2C%20Garcia-Garcia%2C%20M.%20L.%2C%20Gandhi%2C%20N.%2C%20Granich%2C%20R.%20M.%2C%20Hollm-Delgado%2C%20M.%20G.%2C%20Holtz%2C%20T.%20H.%2C%20Iseman%2C%20M.%20D.%2C%20Jarlsberg%2C%20L.%20G.%2C%20Keshavjee%2C%20S.%2C%20Kim%2C%20H.-R.%2C%20Koh%2C%20W.-J.%2C%20Lancaster%2C%20J.%2C%20Lange%2C%20C.%2C%20Lange%2C%20W.%20C.%20M.%20de%2C%20Leimane%2C%20V.%2C%20Leung%2C%20C.%20C.%2C%20Li%2C%20J.%2C%20Menzies%2C%20D.%2C%20Migliori%2C%20G.%20B.%2C%20Mishustin%2C%20S.%20P.%2C%20Mitnick%2C%20C.%20D.%2C%20Narita%2C%20M.%2C%20O%26%23x2019%3BRiordan%2C%20P.%2C%20Pai%2C%20M.%2C%20Palmero%2C%20D.%2C%20Park%2C%20S.%2C%20Pasvol%2C%20G.%2C%20Pe%26%23xF1%3Ba%2C%20J.%2C%20P%26%23xE9%3Brez-Guzm%26%23xE1%3Bn%2C%20C.%2C%20Quelapio%2C%20M.%20I.%20D.%2C%20Ponce-de-Leon%2C%20A.%2C%20Riekstina%2C%20V.%2C%20Robert%2C%20J.%2C%20Royce%2C%20S.%2C%20Schaaf%2C%20H.%20S.%2C%20Seung%2C%20K.%20J.%2C%20Shah%2C%20L.%2C%20Shim%2C%20T.%20S.%2C%20Shin%2C%20S.%20S.%2C%20Shiraishi%2C%20Y.%2C%20Sifuentes-Osornio%2C%20J.%2C%20Sotgiu%2C%20G.%2C%20Strand%2C%20M.%20J.%2C%20Tabarsi%2C%20P.%2C%20Tupasi%2C%20T.%20E.%2C%20Altena%2C%20R.%20van%2C%20Walt%2C%20M.%20V.%20der%2C%20Werf%2C%20T.%20S.%20V.%20der%2C%20Vargas%2C%20M.%20H.%2C%20Viiklepp%2C%20P.%2C%20Westenhouse%2C%20J.%2C%20Yew%2C%20W.%20W.%20and%20Yim%2C%20J.-J.%20%282012%29.%20%3Cb%3EMultidrug%20Resistant%20Pulmonary%20Tuberculosis%20Treatment%20Regimens%20and%20Patient%20Outcomes%3A%20An%20Individual%20Patient%20Data%20Meta-analysis%20of%209%2C153%20Patients%3C%5C%2Fb%3E.%20PLOS%20Med%20%3Ci%3E9%3C%5C%2Fi%3E%2C%20e1001300%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pmed.1001300%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pmed.1001300%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multidrug%20Resistant%20Pulmonary%20Tuberculosis%20Treatment%20Regimens%20and%20Patient%20Outcomes%3A%20An%20Individual%20Patient%20Data%20Meta-analysis%20of%209%2C153%20Patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shama%20D.%22%2C%22lastName%22%3A%22Ahuja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Ashkin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monika%22%2C%22lastName%22%3A%22Avendano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rita%22%2C%22lastName%22%3A%22Banerjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Bauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jamie%20N.%22%2C%22lastName%22%3A%22Bayona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mercedes%20C.%22%2C%22lastName%22%3A%22Becerra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Benedetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcos%22%2C%22lastName%22%3A%22Burgos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosella%22%2C%22lastName%22%3A%22Centis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eward%20D.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chen-Yuan%22%2C%22lastName%22%3A%22Chiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lia%22%2C%22lastName%22%3A%22D%27Ambrosio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathy%22%2C%22lastName%22%3A%22DeRiemer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nguyen%20Huy%22%2C%22lastName%22%3A%22Dung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donald%22%2C%22lastName%22%3A%22Enarson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennis%22%2C%22lastName%22%3A%22Falzon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%22%2C%22lastName%22%3A%22Flanagan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Flood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20L.%22%2C%22lastName%22%3A%22Garcia-Garcia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neel%22%2C%22lastName%22%3A%22Gandhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reuben%20M.%22%2C%22lastName%22%3A%22Granich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20G.%22%2C%22lastName%22%3A%22Hollm-Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20H.%22%2C%22lastName%22%3A%22Holtz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20D.%22%2C%22lastName%22%3A%22Iseman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leah%20G.%22%2C%22lastName%22%3A%22Jarlsberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salmaan%22%2C%22lastName%22%3A%22Keshavjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hye-Ryoun%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Won-Jung%22%2C%22lastName%22%3A%22Koh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joey%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wiel%20C.%20M.%20de%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vaira%22%2C%22lastName%22%3A%22Leimane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chi%20Chiu%22%2C%22lastName%22%3A%22Leung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiehui%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dick%22%2C%22lastName%22%3A%22Menzies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%20B.%22%2C%22lastName%22%3A%22Migliori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergey%20P.%22%2C%22lastName%22%3A%22Mishustin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carole%20D.%22%2C%22lastName%22%3A%22Mitnick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masa%22%2C%22lastName%22%3A%22Narita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philly%22%2C%22lastName%22%3A%22O%27Riordan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madhukar%22%2C%22lastName%22%3A%22Pai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Domingo%22%2C%22lastName%22%3A%22Palmero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seung-kyu%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%22%2C%22lastName%22%3A%22Pasvol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%22%2C%22lastName%22%3A%22Pe%5Cu00f1a%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22P%5Cu00e9rez-Guzm%5Cu00e1n%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20I.%20D.%22%2C%22lastName%22%3A%22Quelapio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alfredo%22%2C%22lastName%22%3A%22Ponce-de-Leon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vija%22%2C%22lastName%22%3A%22Riekstina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jerome%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Royce%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20Simon%22%2C%22lastName%22%3A%22Schaaf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kwonjune%20J.%22%2C%22lastName%22%3A%22Seung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lena%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tae%20Sun%22%2C%22lastName%22%3A%22Shim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonya%20S.%22%2C%22lastName%22%3A%22Shin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuji%22%2C%22lastName%22%3A%22Shiraishi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%22%2C%22lastName%22%3A%22Sifuentes-Osornio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%22%2C%22lastName%22%3A%22Sotgiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Strand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Payam%22%2C%22lastName%22%3A%22Tabarsi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thelma%20E.%22%2C%22lastName%22%3A%22Tupasi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20van%22%2C%22lastName%22%3A%22Altena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martie%20Van%20der%22%2C%22lastName%22%3A%22Walt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tjip%20S.%20Van%20der%22%2C%22lastName%22%3A%22Werf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%20H.%22%2C%22lastName%22%3A%22Vargas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pirett%22%2C%22lastName%22%3A%22Viiklepp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janice%22%2C%22lastName%22%3A%22Westenhouse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wing%20Wai%22%2C%22lastName%22%3A%22Yew%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jae-Joon%22%2C%22lastName%22%3A%22Yim%22%7D%5D%2C%22abstractNote%22%3A%22Dick%20Menzies%20and%20colleagues%20report%20findings%20from%20a%20collaborative%2C%20individual%20patient-level%20meta-analysis%20of%20treatment%20outcomes%20among%20patients%20with%20multidrug-resistant%20tuberculosis.%22%2C%22date%22%3A%2228%20ao%5Cu00fbt%202012%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pmed.1001300%22%2C%22ISSN%22%3A%221549-1676%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjournals.plos.org%5C%2Fplosmedicine%5C%2Farticle%3Fid%3D10.1371%5C%2Fjournal.pmed.1001300%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-25T16%3A02%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22FPRF73U3%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Andr%5Cu00e9jak%20et%20al.%22%2C%22parsedDate%22%3A%222012-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAndr%26%23xE9%3Bjak%2C%20C.%2C%20Veziris%2C%20N.%2C%20Lescure%2C%20X.%2C%20Cadranel%2C%20J.%20and%20Jounieaux%2C%20V.%20%282012%29.%20%3Cb%3EEssai%20CaMoMy%26%23xA0%3B%3A%20%26%23xE9%3Bvaluation%20de%20la%20capacit%26%23xE9%3B%20de%20deux%20sch%26%23xE9%3Bmas%20th%26%23xE9%3Brapeutiques%20%28Clarithromycine%20ou%20Moxifloxacine%29%20%26%23xE0%3B%20n%26%23xE9%3Bgativer%20les%20cultures%20%26%23xE0%3B%20six%20mois%20de%20malades%20porteurs%20d%26%23x2019%3Bune%20infection%20pulmonaire%20%26%23xE0%3B%20Mycobacterium%20xenopi.%20PHRC%20national%202010%3C%5C%2Fb%3E.%20Revue%20des%20Maladies%20Respiratoires%20%3Ci%3E29%2C%20Supplement%201%3C%5C%2Fi%3E%2C%20A25%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2011.10.030%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2011.10.030%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Essai%20CaMoMy%5Cu00a0%3A%20%5Cu00e9valuation%20de%20la%20capacit%5Cu00e9%20de%20deux%20sch%5Cu00e9mas%20th%5Cu00e9rapeutiques%20%28Clarithromycine%20ou%20Moxifloxacine%29%20%5Cu00e0%20n%5Cu00e9gativer%20les%20cultures%20%5Cu00e0%20six%20mois%20de%20malades%20porteurs%20d%5Cu2019une%20infection%20pulmonaire%20%5Cu00e0%20Mycobacterium%20xenopi.%20PHRC%20national%202010%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Andr%5Cu00e9jak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22X.%22%2C%22lastName%22%3A%22Lescure%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Cadranel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Jounieaux%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22January%202012%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.rmr.2011.10.030%22%2C%22ISSN%22%3A%220761-8425%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0761842511004372%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A55%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22QHW3X6E9%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bernard%20et%20al.%22%2C%22parsedDate%22%3A%222012-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBernard%2C%20C.%2C%20Sougakoff%2C%20W.%2C%20Fournier%2C%20A.%2C%20Larnaudie%2C%20S.%2C%20Antoun%2C%20F.%2C%20Robert%2C%20J.%2C%20Brossier%2C%20F.%2C%20Truffot-Pernot%2C%20C.%2C%20Jarlier%2C%20V.%20and%20Veziris%2C%20N.%20%282012%29.%20%3Cb%3EImpact%20of%20a%2014-year%20screening%20programme%20on%20tuberculosis%20transmission%20among%20the%20homeless%20in%20Paris%3C%5C%2Fb%3E.%20Int%20J%20Tuberc%20Lung%20Dis%20%3Ci%3E16%3C%5C%2Fi%3E%2C%20649%26%23x2013%3B655%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.11.0241%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.11.0241%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20a%2014-year%20screening%20programme%20on%20tuberculosis%20transmission%20among%20the%20homeless%20in%20Paris%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Fournier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%22%2C%22lastName%22%3A%22Larnaudie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F%22%2C%22lastName%22%3A%22Antoun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Truffot-Pernot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20To%20evaluate%20the%20impact%20of%20an%20active%20case-finding%20programme%20on%20tuberculosis%20%28TB%29%20transmission%20in%20homeless%20shelters%20in%20Paris%2C%20France.%5CnDESIGN%3A%20Between%201994%20and%201997%2C%20an%20active%20case-finding%20programme%20was%20implemented%20in%20homeless%20shelters%20using%20a%20mobile%20radiological%20screening%20unit%2C%20and%20continued%20from%201997%20to%202007.%20During%20these%20periods%2C%20the%20strains%20isolated%20from%20TB%20cases%20diagnosed%20in%20the%20homeless%20were%20genotyped%20by%20restriction%20fragment%20length%20polymorphism%20analysis%20using%20the%20insertion%20sequence%20IS6110%20as%20a%20probe.%5CnRESULTS%3A%20Between%201994%20and%202007%2C%20313%20new%20TB%20cases%20were%20diagnosed%20among%20the%20homeless%20population%3A%20179%20through%20the%20programme%20among%20shelter%20users%2C%20and%20134%20among%20homeless%20people%20not%20using%20shelters.%20Half%20of%20the%20strains%20were%20clustered%20in%2035%20distinct%20patterns%20%282-48%20cases%5C%2Fcluster%29.%20The%20clustering%20of%20TB%20cases%20steadily%20decreased%20in%20shelters%20during%20the%2013%20years%20of%20the%20survey%2C%20from%2014.3%20to%202.7%20related%20cases%20per%20year%20%28P%20%3C%200.01%29%20and%20from%2075%25%20to%2030%25%20of%20related%20cases%20among%20all%20TB%20cases%20%28P%20%3C%200.01%29.%20In%20contrast%2C%20there%20was%20only%20a%20slight%20trend%20towards%20a%20decrease%20in%20homeless%20people%20not%20using%20shelters.%5CnCONCLUSION%3A%20Active%20case%20finding%20in%20homeless%20shelters%20resulted%20in%20a%20decrease%20in%20case%20clustering%2C%20mainly%20in%20shelter%20users.%20Genotyping%20contributed%20to%20confirming%20the%20positive%20impact%20of%20the%20intervention.%22%2C%22date%22%3A%22May%202012%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.11.0241%22%2C%22ISSN%22%3A%221815-7920%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ingentaconnect.com%5C%2Fcontent%5C%2Fiuatld%5C%2Fijtld%5C%2F2012%5C%2F00000016%5C%2F00000005%5C%2Fart00018%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-04-02T21%3A24%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22X6MXNPGF%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Broutin%20et%20al.%22%2C%22parsedDate%22%3A%222012-11-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBroutin%2C%20V.%2C%20Ba%26%23xF1%3Buls%2C%20A.-L.%2C%20Aubry%2C%20A.%2C%20Keck%2C%20N.%2C%20Choisy%2C%20M.%2C%20Bernardet%2C%20J.-F.%2C%20Michel%2C%20C.%2C%20Raymond%2C%20J.-C.%2C%20Libert%2C%20C.%2C%20Barnaud%2C%20A.%2C%20Stragier%2C%20P.%2C%20Portaels%2C%20F.%2C%20Terru%2C%20D.%2C%20Belon%2C%20C.%2C%20Dereure%2C%20O.%2C%20Gutierrez%2C%20C.%2C%20Boschiroli%2C%20M.-L.%2C%20Perre%2C%20P.%20V.%20D.%2C%20Cambau%2C%20E.%20and%20Godreuil%2C%20S.%20%282012%29.%20%3Cb%3EGenetic%20Diversity%20and%20Population%20Structure%20of%20Mycobacterium%20marinum%3A%20New%20Insights%20into%20Host%20and%20Environmental%20Specificities%3C%5C%2Fb%3E.%20J%20Clin%20Microbiol%20%3Ci%3E50%3C%5C%2Fi%3E%2C%203627%26%23x2013%3B3634%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.01274-12%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.01274-12%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Genetic%20Diversity%20and%20Population%20Structure%20of%20Mycobacterium%20marinum%3A%20New%20Insights%20into%20Host%20and%20Environmental%20Specificities%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Broutin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne-Laure%22%2C%22lastName%22%3A%22Ba%5Cu00f1uls%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Keck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Choisy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Bernardet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Michel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Christophe%22%2C%22lastName%22%3A%22Raymond%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9dric%22%2C%22lastName%22%3A%22Libert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Barnaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pieter%22%2C%22lastName%22%3A%22Stragier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Portaels%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%22%2C%22lastName%22%3A%22Terru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudine%22%2C%22lastName%22%3A%22Belon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Dereure%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%22%2C%22lastName%22%3A%22Gutierrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria-Laura%22%2C%22lastName%22%3A%22Boschiroli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%20Van%20De%22%2C%22lastName%22%3A%22Perre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvain%22%2C%22lastName%22%3A%22Godreuil%22%7D%5D%2C%22abstractNote%22%3A%22Mycobacterium%20marinum%20causes%20a%20systemic%20tuberculosis-like%20disease%20in%20fish%20and%20skin%20infections%20in%20humans%20that%20can%20spread%20to%20deeper%20structures%2C%20resulting%20in%20tenosynovitis%2C%20arthritis%2C%20and%20osteomyelitis.%20However%2C%20little%20information%20is%20available%20concerning%20%28i%29%20the%20intraspecific%20genetic%20diversity%20of%20M.%20marinum%20isolated%20from%20humans%20and%20animals%3B%20%28ii%29%20M.%20marinum%20genotype%20circulation%20in%20the%20different%20ecosystems%2C%20and%20%28iii%29%20the%20link%20between%20M.%20marinum%20genetic%20diversity%20and%20hosts%20%28humans%20and%20fish%29.%20Here%2C%20we%20conducted%20a%20genetic%20study%20on%2089%20M.%20marinum%20isolates%20from%20humans%20%28n%20%3D%2068%29%20and%20fish%20%28n%20%3D%2021%29%20by%20using%20mycobacterial%20interspersed%20repetitive%20units-variable%20number%20of%20tandem%20repeats%20%28MIRU-VNTR%29%20typing.%20The%20results%20show%20that%20the%20M.%20marinum%20population%20is%20genetically%20structured%20not%20only%20according%20to%20the%20host%20but%20also%20according%20to%20the%20ecosystem%20as%20well%20as%20to%20tissue%20tropism%20in%20humans.%20This%20suggests%20the%20existence%20of%20different%20genetic%20pools%20in%20the%20function%20of%20the%20biological%20and%20ecological%20compartments.%20Moreover%2C%20the%20presence%20of%20only%20certain%20M.%20marinum%20genotypes%20in%20humans%20suggests%20a%20different%20zoonotic%20potential%20of%20the%20M.%20marinum%20genotypes.%20Considering%20that%20the%20infection%20is%20linked%20to%20aquarium%20activity%2C%20a%20significant%20genetic%20difference%20was%20also%20detected%20when%20the%20human%20tissue%20tropism%20of%20M.%20marinum%20was%20taken%20into%20consideration%2C%20with%20a%20higher%20genetic%20polymorphism%20in%20strains%20isolated%20from%20patients%20with%20cutaneous%20forms%20than%20from%20individuals%20with%20deeper-structure%20infection.%20It%20appears%20that%20only%20few%20genotypes%20can%20produce%20deeper%20infections%20in%20humans%2C%20suggesting%20that%20the%20immune%20system%20might%20play%20a%20filtering%20role.%22%2C%22date%22%3A%2211%5C%2F01%5C%2F2012%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1128%5C%2FJCM.01274-12%22%2C%22ISSN%22%3A%220095-1137%2C%201098-660X%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjcm.asm.org%5C%2Fcontent%5C%2F50%5C%2F11%5C%2F3627%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222014-09-28T14%3A18%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22GIFVPNTH%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bussone%20et%20al.%22%2C%22parsedDate%22%3A%222012%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBussone%2C%20G.%2C%20Brossier%2C%20F.%2C%20Roudiere%2C%20L.%2C%20Bille%2C%20E.%2C%20Sekkal%2C%20N.%2C%20Charlier%2C%20C.%2C%20Gilquin%2C%20J.%2C%20Lanternier%2C%20F.%2C%20Lecuit%2C%20M.%2C%20Lortholary%2C%20O.%20and%20Catherinot%2C%20E.%20%282012%29.%20%3Cb%3ERecurrent%20Mycobacterium%20avium%20infection%20after%20seven%20years%20of%20latency%20in%20a%20HIV-infected%20patient%20receiving%20efficient%20antiretroviral%20therapy%3C%5C%2Fb%3E.%20Journal%20of%20Infection%20%3Ci%3E64%3C%5C%2Fi%3E%2C%20613%26%23x2013%3B617%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jinf.2011.12.020%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jinf.2011.12.020%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Recurrent%20Mycobacterium%20avium%20infection%20after%20seven%20years%20of%20latency%20in%20a%20HIV-infected%20patient%20receiving%20efficient%20antiretroviral%20therapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guillaume%22%2C%22lastName%22%3A%22Bussone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Roudiere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Bille%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nawal%22%2C%22lastName%22%3A%22Sekkal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Charlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacques%22%2C%22lastName%22%3A%22Gilquin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fanny%22%2C%22lastName%22%3A%22Lanternier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Lecuit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Lortholary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilie%22%2C%22lastName%22%3A%22Catherinot%22%7D%5D%2C%22abstractNote%22%3A%22Summary%5CnWe%20report%20the%20first%20case%20of%20Mycobacterium%20avium%20reactivation%2C%20after%20prolonged%20latency%2C%20in%20a%20HIV-infected%20patient%20receiving%20highly%20active%20antiretroviral%20therapy%20with%20undetectable%20viral%20replication%20and%20normal%20CD4%20cell%20count.%20The%20patient%20presented%20with%20a%20painful%20swollen%20shoulder%20seven%20years%20after%20initial%20M.%20avium%20bacteriaemia.%20Articular%20puncture%20grew%20M.%20avium.%20The%20isolates%20of%20the%20first%20and%20second%20infection%20were%20identical%20using%20repetitive-sequence-based%20Polymerase%20Chain%20Reaction%20analyses.%22%2C%22date%22%3A%22juin%202012%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jinf.2011.12.020%22%2C%22ISSN%22%3A%220163-4453%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0163445311006244%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-25T16%3A05%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22U272CXV3%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cambau%20et%20al.%22%2C%22parsedDate%22%3A%222012-07-31%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECambau%2C%20E.%2C%20Chauffour-Nevejans%2C%20A.%2C%20Tejmar-Kolar%2C%20L.%2C%20Matsuoka%2C%20M.%20and%20Jarlier%2C%20V.%20%282012%29.%20%3Cb%3EDetection%20of%20Antibiotic%20Resistance%20in%20Leprosy%20Using%20GenoType%20LepraeDR%2C%20a%20Novel%20Ready-To-Use%20Molecular%20Test%3C%5C%2Fb%3E.%20PLoS%20Negl%20Trop%20Dis%20%3Ci%3E6%3C%5C%2Fi%3E%2C%20e1739%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0001739%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0001739%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Detection%20of%20Antibiotic%20Resistance%20in%20Leprosy%20Using%20GenoType%20LepraeDR%2C%20a%20Novel%20Ready-To-Use%20Molecular%20Test%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour-Nevejans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liana%22%2C%22lastName%22%3A%22Tejmar-Kolar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masanori%22%2C%22lastName%22%3A%22Matsuoka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%5D%2C%22abstractNote%22%3A%22Author%20SummaryAlthough%20leprosy%20is%20a%20curable%20disease%20using%20a%20combination%20of%20antibiotics%20for%20one%20year%2C%20the%20transmission%20is%20still%20active%20with%20230%2C000%20new%20cases%20in%202010.%20Drug%20resistance%20has%20been%20described%20and%20may%20prevent%20eradication%20of%20the%20disease.%20The%20infectious%20agent%20causing%20leprosy%2C%20Mycobacterium%20leprae%2C%20is%20not%20growing%20in%20vitro%20and%20antibiotic%20susceptibility%20testing%20is%20possible%20only%20in%20the%20mouse%20footpad%20model%20that%20requires%20a%20one%20year%20experiment.%20Consequently%20this%20testing%20is%20rarely%20done%20and%20antibiotic%20resistance%20rates%20in%20leprosy%20are%20unknown.%20This%20is%20the%20reason%20why%20we%20endeavored%20to%20set%20a%20new%20diagnosis%20test%20that%20detects%20for%20antibiotic%20resistance%20in%20M.%20leprae.%20The%20test%20is%20based%20on%20the%20method%20of%20a%20DNA%20strip%20test%20with%20a%20multiplex%20PCR%20followed%20by%20reverse%20hybridization.%20It%20was%20developed%20as%20an%20easy-to-use%20test%20and%20it%20will%20be%20available%20in%20endemic%20countries%2C%20where%20these%20kinds%20of%20strip%20tests%20are%20already%20used%20for%20detection%20of%20drug%20resistance%20in%20tuberculosis.%20The%20results%20of%20the%20new%20test%2C%20Genotype%20LepraeDR%2C%20performed%20on%20120%20M.%20leprae%20strains%20were%20concordant%20with%20those%20of%20the%20standard%20PCR%20sequencing%20and%20mouse%20footpad%20susceptibility%20testing.%22%2C%22date%22%3A%22July%2031%2C%202012%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pntd.0001739%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fdx.doi.org%5C%2F10.1371%5C%2Fjournal.pntd.0001739%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T18%3A04%3A09Z%22%7D%7D%2C%7B%22key%22%3A%225585VGWC%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cosson%20et%20al.%22%2C%22parsedDate%22%3A%222012-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECosson%2C%20M.-A.%2C%20Bertrand%2C%20J.-B.%2C%20Martin%2C%20C.%2C%20Veziris%2C%20N.%2C%20Picard%2C%20C.%2C%20Goulvestre%2C%20C.%2C%20Coignard%2C%20S.%2C%20Benoit%2C%20J.-P.%2C%20Silvera%2C%20S.%2C%20Moro%2C%20M.-R.%2C%20Poyart%2C%20C.%20and%20Morand%2C%20P.%20C.%20%282012%29.%20%3Cb%3ETemporal%20interferon-gamma%20release%20response%20to%20Mycobacterium%20kansasii%20infection%20in%20an%20anorexia%20nervosa%20patient%3C%5C%2Fb%3E.%20J%20Med%20Microbiol%20%3Ci%3E61%3C%5C%2Fi%3E%2C%201617%26%23x2013%3B1620%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1099%5C%2Fjmm.0.042739-0%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1099%5C%2Fjmm.0.042739-0%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Temporal%20interferon-gamma%20release%20response%20to%20Mycobacterium%20kansasii%20infection%20in%20an%20anorexia%20nervosa%20patient%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Anne%22%2C%22lastName%22%3A%22Cosson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Baptiste%22%2C%22lastName%22%3A%22Bertrand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cl%5Cu00e9mence%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Capucine%22%2C%22lastName%22%3A%22Picard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Goulvestre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Coignard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Pierre%22%2C%22lastName%22%3A%22Benoit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Silvera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Rose%22%2C%22lastName%22%3A%22Moro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Poyart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%20C%22%2C%22lastName%22%3A%22Morand%22%7D%5D%2C%22abstractNote%22%3A%22Due%20to%20the%20differences%20in%20the%20management%20of%20Mycobacterium%20kansasii%20disease%20and%20tuberculosis%2C%20an%20accurate%20diagnosis%20is%20required.%20This%20report%2C%20which%20describes%20what%20we%20believe%20to%20be%20the%20first%20documented%20case%20of%20M.%20kansasii%20infection%20in%20a%20patient%20suffering%20from%20anorexia%20nervosa%2C%20sheds%20light%20on%20the%20possible%20occurrence%20of%20a%20non-tuberculous%20mycobacterial%20infection%20that%20can%20mimic%20tuberculosis%2C%20on%20the%20risk%20of%20a%20misleading%20interpretation%20of%20interferon-gamma%20release%20assays%2C%20and%20on%20the%20temporal%20response%20to%20these%20tests.%22%2C%22date%22%3A%22Nov%202012%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1099%5C%2Fjmm.0.042739-0%22%2C%22ISSN%22%3A%221473-5644%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.microbiologyresearch.org%5C%2Fcontent%5C%2Fjournal%5C%2Fjmm%5C%2F10.1099%5C%2Fjmm.0.042739-0%23tab2%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-04-02T21%3A26%3A03Z%22%7D%7D%2C%7B%22key%22%3A%2294P7HHSA%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Darmon%20et%20al.%22%2C%22parsedDate%22%3A%222012-02-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDarmon%2C%20A.%2C%20Piton%2C%20J.%2C%20Rou%26%23xE9%3B%2C%20M.%2C%20Petrella%2C%20S.%2C%20Aubry%2C%20A.%20and%20Mayer%2C%20C.%20%282012%29.%20%3Cb%3EPurification%2C%20crystallization%20and%20preliminary%20X-ray%20crystallographic%20studies%20of%20the%20Mycobacterium%20tuberculosis%20DNA%20gyrase%20CTD%3C%5C%2Fb%3E.%20Acta%20Crystallogr%20Sect%20F%20Struct%20Biol%20Cryst%20Commun%20%3Ci%3E68%3C%5C%2Fi%3E%2C%20178%26%23x2013%3B180%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1107%5C%2FS1744309111051888%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1107%5C%2FS1744309111051888%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Purification%2C%20crystallization%20and%20preliminary%20X-ray%20crystallographic%20studies%20of%20the%20Mycobacterium%20tuberculosis%20DNA%20gyrase%20CTD%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Am%5Cu00e9lie%22%2C%22lastName%22%3A%22Darmon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00e9mie%22%2C%22lastName%22%3A%22Piton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%5Cu00e9lanie%22%2C%22lastName%22%3A%22Rou%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22Petrella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudine%22%2C%22lastName%22%3A%22Mayer%22%7D%5D%2C%22abstractNote%22%3A%22Mycobacterium%20tuberculosis%20DNA%20gyrase%2C%20a%20nanomachine%20involved%20in%20regulation%20of%20DNA%20topology%2C%20is%20the%20only%20type%20II%20topoisomerase%20present%20in%20this%20organism%20and%20hence%20is%20the%20sole%20target%20of%20fluoroquinolone%20in%20the%20treatment%20of%20tuberculosis.%20The%20C-terminal%20domain%20%28CTD%29%20of%20the%20DNA%20gyrase%20A%20subunit%20possesses%20a%20unique%20feature%2C%20the%20ability%20to%20wrap%20DNA%20in%20a%20chiral%20manner%2C%20that%20plays%20an%20essential%20role%20during%20the%20catalytic%20cycle.%20A%20construct%20of%2036%20kDa%20corresponding%20to%20this%20domain%20has%20been%20overproduced%2C%20purified%20and%20crystallized.%20Diffraction%20data%20were%20collected%20to%201.55%20%5Cu00c5%20resolution.%20Cleavage%20of%20the%20N-terminal%20His%20tag%20was%20crucial%20for%20obtaining%20crystals.%20The%20crystals%20belonged%20to%20space%20group%20P2%281%292%281%292%281%29%2C%20with%20one%20molecule%20in%20the%20asymmetric%20unit%20and%20a%20low%20solvent%20content%20%2833%25%29.%20This%20is%20the%20first%20report%20of%20the%20crystallization%20and%20preliminary%20X-ray%20diffraction%20studies%20of%20a%20DNA%20gyrase%20CTD%20from%20a%20species%20that%20contains%20one%20unique%20type%20II%20topoisomerase.%22%2C%22date%22%3A%22Feb%201%2C%202012%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1107%5C%2FS1744309111051888%22%2C%22ISSN%22%3A%221744-3091%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3274397%5C%2F%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-04-02T21%3A27%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22X5WTRHD4%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22de%20Beer%20et%20al.%22%2C%22parsedDate%22%3A%222012-03-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3Ede%20Beer%2C%20J.%20L.%2C%20Kremer%2C%20K.%2C%20K%26%23xF6%3Bdm%26%23xF6%3Bn%2C%20C.%2C%20Supply%2C%20P.%2C%20Soolingen%2C%20D.%20van%20and%202009%2C%20%20the%20G.%20N.%20for%20the%20M.%20S.%20of%20T.%20%282012%29.%20%3Cb%3EFirst%20Worldwide%20Proficiency%20Study%20on%20Variable-Number%20Tandem-Repeat%20Typing%20of%20Mycobacterium%20tuberculosis%20Complex%20Strains%3C%5C%2Fb%3E.%20J%20Clin%20Microbiol%20%3Ci%3E50%3C%5C%2Fi%3E%2C%20662%26%23x2013%3B669%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.00607-11%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.00607-11%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22First%20Worldwide%20Proficiency%20Study%20on%20Variable-Number%20Tandem-Repeat%20Typing%20of%20Mycobacterium%20tuberculosis%20Complex%20Strains%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22de%20Beer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristin%22%2C%22lastName%22%3A%22Kremer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Csaba%22%2C%22lastName%22%3A%22K%5Cu00f6dm%5Cu00f6n%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philip%22%2C%22lastName%22%3A%22Supply%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dick%20van%22%2C%22lastName%22%3A%22Soolingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22the%20Global%20Network%20for%20the%20Molecular%20Surveillance%20of%20Tuberculosis%22%2C%22lastName%22%3A%222009%22%7D%5D%2C%22abstractNote%22%3A%22Although%20variable-number%20tandem-repeat%20%28VNTR%29%20typing%20has%20gained%20recognition%20as%20the%20new%20standard%20for%20the%20DNA%20fingerprinting%20of%20Mycobacterium%20tuberculosis%20complex%20%28MTBC%29%20isolates%2C%20external%20quality%20control%20programs%20have%20not%20yet%20been%20developed.%20Therefore%2C%20we%20organized%20the%20first%20multicenter%20proficiency%20study%20on%2024-locus%20VNTR%20typing.%20Sets%20of%2030%20DNAs%20of%20MTBC%20strains%2C%20including%2010%20duplicate%20DNA%20samples%2C%20were%20distributed%20among%2037%20participating%20laboratories%20in%2030%20different%20countries%20worldwide.%20Twenty-four%20laboratories%20used%20an%20in-house-adapted%20method%20with%20fragment%20sizing%20by%20gel%20electrophoresis%20or%20an%20automated%20DNA%20analyzer%2C%20nine%20laboratories%20used%20a%20commercially%20available%20kit%2C%20and%20four%20laboratories%20used%20other%20methods.%20The%20intra-%20and%20interlaboratory%20reproducibilities%20of%20VNTR%20typing%20varied%20from%200%25%20to%20100%25%2C%20with%20averages%20of%2072%25%20and%2060%25%2C%20respectively.%20Twenty%20of%20the%2037%20laboratories%20failed%20to%20amplify%20particular%20VNTR%20loci%3B%20if%20these%20missing%20results%20were%20ignored%2C%20the%20number%20of%20laboratories%20with%20100%25%20interlaboratory%20reproducibility%20increased%20from%201%20to%205.%20The%20average%20interlaboratory%20reproducibility%20of%20VNTR%20typing%20using%20a%20commercial%20kit%20was%20better%20%2888%25%29%20than%20that%20of%20in-house-adapted%20methods%20using%20a%20DNA%20analyzer%20%2870%25%29%20or%20gel%20electrophoresis%20%2850%25%29.%20Eleven%20laboratories%20using%20in-house-adapted%20manual%20typing%20or%20automated%20typing%20scored%20inter-%20and%20intralaboratory%20reproducibilities%20of%2080%25%20or%20higher%2C%20which%20suggests%20that%20these%20approaches%20can%20be%20used%20in%20a%20reliable%20way.%20In%20conclusion%2C%20this%20first%20multicenter%20study%20has%20documented%20the%20worldwide%20quality%20of%20VNTR%20typing%20of%20MTBC%20strains%20and%20highlights%20the%20importance%20of%20international%20quality%20control%20to%20improve%20genotyping%20in%20the%20future.%22%2C%22date%22%3A%2203%5C%2F01%5C%2F2012%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1128%5C%2FJCM.00607-11%22%2C%22ISSN%22%3A%220095-1137%2C%201098-660X%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjcm.asm.org%5C%2Fcontent%5C%2F50%5C%2F3%5C%2F662%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-25T16%3A01%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22M9C7WMI9%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Dutilh%20et%20al.%22%2C%22parsedDate%22%3A%222012-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDutilh%2C%20J.%2C%20Caron%2C%20F.%2C%20Bourgoin%2C%20A.%2C%20Veziris%2C%20N.%20and%20Meurice%2C%20J.-C.%20%282012%29.%20%3Cb%3EUn%20cas%20atypique%20de%20mycobact%26%23xE9%3Brie%3C%5C%2Fb%3E.%20Revue%20des%20Maladies%20Respiratoires%20%3Ci%3E29%3C%5C%2Fi%3E%2C%201182%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2012.10.014%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2012.10.014%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Un%20cas%20atypique%20de%20mycobact%5Cu00e9rie%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Dutilh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Caron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Bourgoin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.-C.%22%2C%22lastName%22%3A%22Meurice%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22November%202012%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.rmr.2012.10.014%22%2C%22ISSN%22%3A%220761-8425%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0761842512003397%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A50%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22KRFPI4XK%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fillion%20and%20Veziris%22%2C%22parsedDate%22%3A%222012-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFillion%2C%20A.%20and%20Veziris%2C%20N.%20%282012%29.%20%3Cb%3E%26%23xC9%3Bvaluation%20de%20l%26%23x2019%3Befficacit%26%23xE9%3B%20de%20la%20moxifloxacine%20dans%20le%20traitement%20des%20tuberculoses%20%26%23xE0%3B%20bacilles%20r%26%23xE9%3Bsistants%20%26%23xE0%3B%20l%26%23x2019%3Bofloxacine%3C%5C%2Fb%3E.%20Revue%20des%20Maladies%20Respiratoires%20%3Ci%3E29%2C%20Supplement%201%3C%5C%2Fi%3E%2C%20A12%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2011.10.961%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2011.10.961%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22%5Cu00c9valuation%20de%20l%5Cu2019efficacit%5Cu00e9%20de%20la%20moxifloxacine%20dans%20le%20traitement%20des%20tuberculoses%20%5Cu00e0%20bacilles%20r%5Cu00e9sistants%20%5Cu00e0%20l%5Cu2019ofloxacine%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Fillion%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22January%202012%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.rmr.2011.10.961%22%2C%22ISSN%22%3A%220761-8425%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0761842511013684%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A55%3A39Z%22%7D%7D%2C%7B%22key%22%3A%227NKA6KXF%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Laboratoire%20de%20bact%5Cu00e9riologie%20et%20d%27hygi%5Cu00e8ne%2C%20h%5Cu00f4pital%20la%20Piti%5Cu00e9-Salp%5Cu00eatri%5Cu00e8re%2C%20AP-HP%2C%20FRA%20et%20al.%22%2C%22parsedDate%22%3A%222012%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELaboratoire%20de%20bact%26%23xE9%3Briologie%20et%20d%26%23x2019%3Bhygi%26%23xE8%3Bne%2C%20h%26%23xF4%3Bpital%20la%20Piti%26%23xE9%3B-Salp%26%23xEA%3Btri%26%23xE8%3Bre%2C%20AP-HP%2C%20FRA%2C%20CNR%20des%20mycobact%26%23xE9%3Bries%20et%20de%20la%20r%26%23xE9%3Bsistance%20des%20mycobact%26%23xE9%3Bries%20aux%20antituberculeux%2C%20FRA%2C%20Laboratoire%20de%20bact%26%23xE9%3Briologie%20et%20d%26%23x2019%3Bhygi%26%23xE8%3Bne%2C%20EA%201541%5C%2FER5%2C%20universit%26%23xE9%3B%20Pierre-et-Marie-Curie%2C%20FRA%2C%20Ces%202%20auteurs%20ont%20contribu%26%23xE9%3B%20%26%23xE0%3B%20part%20%26%23xE9%3Bgale%20%26%23xE0%3B%20la%20r%26%23xE9%3Bdaction%20du%20manuscrit%2C%20FRA%2C%20A%2C%20F.%2C%20A%2C%20P.%2C%20N%2C%20V.%20and%20A%2C%20A.%20%282012%29.%20%3Cb%3EPlace%20des%20fluoroquinolones%20dans%20le%20traitement%20des%20tuberculoses%20%26%23xE0%3B%20bacilles%20r%26%23xE9%3Bsistants%26%23x202F%3B%3A%20La%20tuberculose%20en%202012%3C%5C%2Fb%3E.%20La%20Lettre%20du%20pneumologue%20%3Ci%3E15%3C%5C%2Fi%3E%2C%2012%26%23x2013%3B16%2C%20URL%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fwww.refdoc.fr%5C%2FDetailnotice%3Fidarticle%27%3Ehttp%3A%5C%2F%5C%2Fwww.refdoc.fr%5C%2FDetailnotice%3Fidarticle%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Place%20des%20fluoroquinolones%20dans%20le%20traitement%20des%20tuberculoses%20%5Cu00e0%20bacilles%20r%5Cu00e9sistants%20%3A%20La%20tuberculose%20en%202012%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Laboratoire%20de%20bact%5Cu00e9riologie%20et%20d%27hygi%5Cu00e8ne%2C%20h%5Cu00f4pital%20la%20Piti%5Cu00e9-Salp%5Cu00eatri%5Cu00e8re%2C%20AP-HP%2C%20FRA%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22CNR%20des%20mycobact%5Cu00e9ries%20et%20de%20la%20r%5Cu00e9sistance%20des%20mycobact%5Cu00e9ries%20aux%20antituberculeux%2C%20FRA%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Laboratoire%20de%20bact%5Cu00e9riologie%20et%20d%27hygi%5Cu00e8ne%2C%20EA%201541%5C%2FER5%2C%20universit%5Cu00e9%20Pierre-et-Marie-Curie%2C%20FRA%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Ces%202%20auteurs%20ont%20contribu%5Cu00e9%20%5Cu00e0%20part%20%5Cu00e9gale%20%5Cu00e0%20la%20r%5Cu00e9daction%20du%20manuscrit%2C%20FRA%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22FILLION%22%2C%22lastName%22%3A%22A%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PANTEL%22%2C%22lastName%22%3A%22A%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22VEZIRIS%22%2C%22lastName%22%3A%22N%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22AUBRY%22%2C%22lastName%22%3A%22A%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222012%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221292-5977%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.refdoc.fr%5C%2FDetailnotice%3Fidarticle%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A57%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22KKA6U77X%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Legout%20et%20al.%22%2C%22parsedDate%22%3A%222012-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELegout%2C%20L.%2C%20Ettahar%2C%20N.%2C%20Massongo%2C%20M.%2C%20Veziris%2C%20N.%2C%20Ajana%2C%20F.%2C%20Beltrand%2C%20E.%20and%20Senneville%2C%20E.%20%282012%29.%20%3Cb%3EOsteomyelitis%20of%20the%20wrist%20caused%20by%20Mycobacterium%20arupense%20in%20an%20immunocompetent%20patient%3A%20a%20unique%20case%3C%5C%2Fb%3E.%20Int%20J%20Infect%20Dis%20%3Ci%3E16%3C%5C%2Fi%3E%2C%20e761-762%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijid.2012.05.007%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijid.2012.05.007%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Osteomyelitis%20of%20the%20wrist%20caused%20by%20Mycobacterium%20arupense%20in%20an%20immunocompetent%20patient%3A%20a%20unique%20case%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L%22%2C%22lastName%22%3A%22Legout%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Ettahar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Massongo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F%22%2C%22lastName%22%3A%22Ajana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Beltrand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Senneville%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Oct%202012%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijid.2012.05.007%22%2C%22ISSN%22%3A%221878-3511%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ijidonline.com%5C%2Farticle%5C%2FS1201-9712%2812%2900159-2%5C%2Ffulltext%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-04-02T21%3A27%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22ZCC5MGPH%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lhuillier%20et%20al.%22%2C%22parsedDate%22%3A%222012-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELhuillier%2C%20E.%2C%20Brugi%26%23xE8%3Bre%2C%20O.%2C%20Veziris%2C%20N.%2C%20Danel%2C%20C.%2C%20Mourvilliers%2C%20B.%2C%20Mal%2C%20H.%2C%20Dauriat%2C%20G.%20and%20Ruimy%2C%20R.%20%282012%29.%20%3Cb%3ERelapsing%20Mycobacterium%20genavense%20infection%20as%20a%20cause%20of%20late%20death%20in%20a%20lung%20transplant%20recipient%3A%20case%20report%20and%20review%20of%20the%20literature%3C%5C%2Fb%3E.%20Exp%20Clin%20Transplant%20%3Ci%3E10%3C%5C%2Fi%3E%2C%20618%26%23x2013%3B620%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.6002%5C%2Fect.2012.0052%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.6002%5C%2Fect.2012.0052%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Relapsing%20Mycobacterium%20genavense%20infection%20as%20a%20cause%20of%20late%20death%20in%20a%20lung%20transplant%20recipient%3A%20case%20report%20and%20review%20of%20the%20literature%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elodie%22%2C%22lastName%22%3A%22Lhuillier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Brugi%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Danel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%22%2C%22lastName%22%3A%22Mourvilliers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Herv%5Cu00e9%22%2C%22lastName%22%3A%22Mal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ga%5Cu00eblle%22%2C%22lastName%22%3A%22Dauriat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%22%2C%22lastName%22%3A%22Ruimy%22%7D%5D%2C%22abstractNote%22%3A%22Mycobacterium%20genavense%20is%20recognized%20as%20a%20life-threatening%20pathogen%20in%20severely%20immunocompromised%20patients%2C%20mostly%20in%20those%20with%20advanced%20human%20immunodeficiency%20virus%20infection.%20We%20report%20a%20case%20of%20M.%20genavense%20infection%20in%20a%20lung-transplant%20recipient%20with%20late-onset%20death%20occurring%20from%20disseminated%20infection.%20In%20human%20immunodeficiency%20virus-negative%20patients%2C%20there%20exist%20only%20about%2010%20reports%20of%20disseminated%20M.%20genavense%20infection%20in%20immunocompromised%20hosts%3B%20and%20to%20our%20knowledge%2C%20this%20is%20a%20first%20reported%20case%20of%20M.%20genavense%20infection%20after%20a%20lung%20transplant.%20Diagnosis%20of%20M.%20genavense%20was%20obtained%20only%20with%20nucleic%20acid-based%20identification%20technique%2C%20as%20frequently%20observed%20in%20a%20few%20cases%20of%20human%20immunodeficiency%20virus-negative%20patients.%20A%20striking%20feature%20was%20the%20recurrence%20of%20this%20infection%20in%20our%20patient%20after%20a%20seemingly%20infection-free%20period%20of%203%20years.%20Because%20M.%20genavense%20infection%20can%20be%20life-threatening%2C%20clinicians%20must%20be%20aware%20of%20the%20frequent%20requirement%20for%20nucleic-acid-based%20identification%20for%20its%20diagnosis.%22%2C%22date%22%3A%22Dec%202012%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.6002%5C%2Fect.2012.0052%22%2C%22ISSN%22%3A%222146-8427%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ectrx.org%5C%2Fforms%5C%2Fectrxcontentshow.php%3Fyear%3D2012%26volume%3D10%26issue%3D6%26supplement%3D0%26makale_no%3D0%26spage_number%3D618%26content_type%3DFULL%2520TEXT%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-04-02T21%3A28%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22JWZATJTE%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Maruri%20et%20al.%22%2C%22parsedDate%22%3A%222012-04-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMaruri%2C%20F.%2C%20Sterling%2C%20T.%20R.%2C%20Kaiga%2C%20A.%20W.%2C%20Blackman%2C%20A.%2C%20Heijden%2C%20Y.%20F.%20van%20der%2C%20Mayer%2C%20C.%2C%20Cambau%2C%20E.%20and%20Aubry%2C%20A.%20%282012%29.%20%3Cb%3EA%20systematic%20review%20of%20gyrase%20mutations%20associated%20with%20fluoroquinolone-resistant%20Mycobacterium%20tuberculosis%20and%20a%20proposed%20gyrase%20numbering%20system%3C%5C%2Fb%3E.%20J%20Antimicrob%20Chemother%20%3Ci%3E67%3C%5C%2Fi%3E%2C%20819%26%23x2013%3B831%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkr566%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkr566%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20systematic%20review%20of%20gyrase%20mutations%20associated%20with%20fluoroquinolone-resistant%20Mycobacterium%20tuberculosis%20and%20a%20proposed%20gyrase%20numbering%20system%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20W.%22%2C%22lastName%22%3A%22Kaiga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amondrea%22%2C%22lastName%22%3A%22Blackman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuri%20F.%20van%20der%22%2C%22lastName%22%3A%22Heijden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudine%22%2C%22lastName%22%3A%22Mayer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22Fluoroquinolone%20resistance%20in%20Mycobacterium%20tuberculosis%20has%20become%20increasingly%20important.%20A%20review%20of%20mutations%20in%20DNA%20gyrase%2C%20the%20fluoroquinolone%20target%2C%20is%20needed%20to%20improve%20the%20molecular%20detection%20of%20resistance.%20We%20performed%20a%20systematic%20review%20of%20studies%20reporting%20mutations%20in%20DNA%20gyrase%20genes%20in%20clinical%20M.%20tuberculosis%20isolates.%20From%2042%20studies%20that%20met%20inclusion%20criteria%2C%201220%20fluoroquinolone-resistant%20M.%20tuberculosis%20isolates%20underwent%20sequencing%20of%20the%20quinolone%20resistance-determining%20region%20%28QRDR%29%20of%20gyrA%3B%20780%20%2864%25%29%20had%20mutations.%20The%20QRDR%20of%20gyrB%20was%20sequenced%20in%20534%20resistant%20isolates%3B%2017%20%283%25%29%20had%20mutations.%20Mutations%20at%20gyrA%20codons%2090%2C%2091%20or%2094%20were%20present%20in%20654%5C%2F1220%20%2854%25%29%20resistant%20isolates.%20Four%20different%20GyrB%20numbering%20systems%20were%20reported%2C%20resulting%20in%20mutation%20location%20discrepancies.%20We%20propose%20a%20consensus%20numbering%20system.%20Most%20fluoroquinolone-resistant%20M.%20tuberculosis%20isolates%20had%20mutations%20in%20DNA%20gyrase%2C%20but%20a%20substantial%20proportion%20did%20not.%20The%20proposed%20consensus%20numbering%20system%20can%20improve%20molecular%20detection%20of%20resistance%20and%20identification%20of%20novel%20mutations.%22%2C%22date%22%3A%2204%5C%2F01%5C%2F2012%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1093%5C%2Fjac%5C%2Fdkr566%22%2C%22ISSN%22%3A%220305-7453%2C%201460-2091%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjac.oxfordjournals.org%5C%2Fcontent%5C%2F67%5C%2F4%5C%2F819%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A53%3A25Z%22%7D%7D%2C%7B%22key%22%3A%226VTT9W66%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Meyssonnier%20et%20al.%22%2C%22parsedDate%22%3A%222012-06-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMeyssonnier%2C%20V.%2C%20Veziris%2C%20N.%2C%20Bastian%2C%20S.%2C%20Texier-Maugein%2C%20J.%2C%20Jarlier%2C%20V.%20and%20Robert%2C%20J.%20%282012%29.%20%3Cb%3EIncrease%20in%20primary%20drug%20resistance%20of%20Mycobacterium%20tuberculosis%20in%20younger%20birth%20cohorts%20in%20France%3C%5C%2Fb%3E.%20Journal%20of%20Infection%20%3Ci%3E64%3C%5C%2Fi%3E%2C%20589%26%23x2013%3B595%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jinf.2012.01.013%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jinf.2012.01.013%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Increase%20in%20primary%20drug%20resistance%20of%20Mycobacterium%20tuberculosis%20in%20younger%20birth%20cohorts%20in%20France%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanina%22%2C%22lastName%22%3A%22Meyssonnier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvaine%22%2C%22lastName%22%3A%22Bastian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeanne%22%2C%22lastName%22%3A%22Texier-Maugein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnMonitoring%20of%20primary%20drug%20resistance%20is%20of%20interest%20for%20long-term%20evaluation%20of%20the%20efficacy%20of%20a%20national%20tuberculosis%20program.%20The%20objective%20was%20to%20describe%20changes%20over%20time%20in%20primary%20drug%20resistance%20among%20new%20tuberculosis%20patients.%5CnMethods%5CnStratified%20analysis%20by%20birth%20cohorts%2C%20region%20of%20birth%2C%20HIV-coinfection%20of%20data%20from%2014%2C610%20culture-positive%20new%20tuberculosis%20patients%20diagnosed%20by%20a%20network%20of%20university%20hospitals%20between%201995%20and%202008.%5CnResults%5CnHalf%20of%20the%20patients%20were%20foreign-born%2C%20and%209%25%20HIV-coinfected.%20For%20foreign-born%20and%20French-born%20patients%2C%20there%20was%20an%20upward%20trend%20in%20resistance%20rates%20to%20streptomycin%2C%20isoniazid%2C%20and%20rifampicin%20from%20the%20oldest%20to%20the%20youngest%20cohorts.%20For%20a%20same%20age%20at%20tuberculosis%20diagnosis%2C%20the%20risk%20of%20isoniazid%20resistance%20was%20higher%20in%20younger%20cohorts%2C%20revealing%20a%20cohort%20effect.%20Among%20French-born%20patients%2C%20the%20only%20factor%20independently%20associated%20with%20primary%20resistance%20to%20streptomycin%2C%20or%20isoniazid%20was%20birth%20after%201950%2C%20and%20particularly%20after%201980.%20Risk%20of%20streptomycin%20resistance%20increased%20in%20youngest%20cohorts%20among%20European-born%20patients.%20HIV-coinfection%20was%20associated%20to%20rifampicin%20resistance%20among%20foreign-born%20and%20French-born%20patients%2C%5CnConclusions%5CnTheses%20results%20indicate%20that%20among%20French-born%20patients%2C%20isoniazid-resistant%20strains%20are%20currently%20circulating%20in%20younger%20patients%20that%20are%20more%20likely%20to%20be%20infected%20recently%2C%20and%20that%20among%20foreign-born%20patients%2C%20HIV-coinfection%20is%20a%20strong%20risk%20factor%20for%20primary%20resistance.%22%2C%22date%22%3A%222012-06-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jinf.2012.01.013%22%2C%22ISSN%22%3A%220163-4453%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0163445312000151%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-04-02T21%3A31%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22X52RNYNK%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Meyssonnier%20et%20al.%22%2C%22parsedDate%22%3A%222012-12-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMeyssonnier%2C%20V.%2C%20Guihot%2C%20A.%2C%20Chevet%2C%20K.%2C%20Veziris%2C%20N.%2C%20Assoumou%2C%20L.%2C%20Bourgarit%2C%20A.%2C%20Costagliola%2C%20D.%2C%20Caumes%2C%20E.%20and%20Carcelin%2C%20G.%20%282012%29.%20%3Cb%3EPerformance%20of%20Quantiferon%26%23xAE%3B%20for%20the%20diagnosis%20TB%3C%5C%2Fb%3E.%20M%26%23xE9%3Bdecine%20et%20Maladies%20Infectieuses%20%3Ci%3E42%3C%5C%2Fi%3E%2C%20579%26%23x2013%3B584%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2012.08.003%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2012.08.003%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Performance%20of%20Quantiferon%5Cu00ae%20for%20the%20diagnosis%20TB%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Meyssonnier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Guihot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Chevet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Assoumou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Bourgarit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Costagliola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Caumes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Carcelin%22%7D%5D%2C%22abstractNote%22%3A%22Objectives%5CnThe%20aim%20of%20the%20study%20was%20to%20evaluate%20the%20performance%20of%20Quantiferon%20Gold-In-Tube%5Cu00ae%20%28QFN%29%20for%20the%20diagnosis%20of%20tuberculosis%20%28TB%29%20during%20hospitalization%20in%20an%20infectious%20diseases%20department.%5CnPatients%20and%20methods%5CnQFN%20was%20performed%20in%20245%20patients%20recently%20hospitalized%20for%20suspected%20TB.%20Subsets%20of%20patients%20underwent%20tuberculin%20skin%20tests%20%28TST%29%2C%20and%20microbiological%20cultures%20were%20performed.%5CnResult%5CnTB%20was%20diagnosed%20in%2057%20%2823%25%29%20patients%3A%20pulmonary%20in%2023%20%2840%25%29%2C%20extrapulmonary%20in%2016%20%2828%25%29%2C%20and%20disseminated%20in%2018%20%2832%25%29.%20Seventeen%20%2830%25%29%20of%20these%20TB%20patients%20were%20immunocompromised%2C%20including%2012%20with%20HIV%20infection.%20The%20sensitivity%20of%20QFN%20was%2074%25%2C%20its%20specificity%2056%25%2C%20its%20positive%20predictive%20value%2043%25%20and%20negative%20predictive%20value%20%28NPV%29%2092%25.%20The%20sensitivity%20was%20similar%20in%20pulmonary%20and%20extrapulmonary%20TB%20but%20lower%20in%20disseminated%20TB%2C%20although%20not%20significantly%20so.%20The%20sensitivity%20was%20also%20lower%20%28P%3D0.04%29%20in%20immunocompromised%20patients.%20The%20specificity%20was%20lower%20in%20migrants%20than%20in%20native%20French%20patients%20%28P%3D0.01%29%2C%20and%20lower%20in%20patients%20with%20a%20history%20of%20TB%20than%20in%20those%20without%20%28P%3C0.001%29.%20Finally%2C%20combining%20culture%20with%20QFN%20significantly%20increased%20the%20sensitivity%20%28P%3D0.008%29%2C%20and%20produced%20a%20higher%20NPV%2C%20as%20for%20the%20combination%20with%20TST%2C%20but%20not%20significantly%20different%20than%20with%20QFN%20alone.%5CnConclusion%5CnThe%20performance%20of%20QFN%20was%20weak%20in%20this%20context%2C%20especially%20in%20subgroups%20at%20high%20risk%20for%20latent%20TB.%20However%2C%20combined%20negative%20results%20of%20QFN%20or%20TST%20and%20culture%20could%20be%20useful%20to%20rule%20out%20active%20TB.%5CnR%5Cu00e9sum%5Cu00e9%5CnObjectif%5Cn%5Cu00c9valuer%20la%20performance%20du%20Quantiferon%5Cu00ae%20pour%20le%20diagnostic%20de%20la%20tuberculose%20active%20lors%20de%20l%5Cu2019hospitalisation%20en%20maladies%20infectieuses.%5CnPatients%20et%20m%5Cu00e9thodes%5CnLe%20Quantif%5Cu00e9ron%5Cu00ae%20a%20%5Cu00e9t%5Cu00e9%20test%5Cu00e9%20chez%20245%5Cu00a0patients%20hospitalis%5Cu00e9s%20pour%20suspicion%20de%20tuberculose%20en%20plus%20d%5Cu2019une%20intradermor%5Cu00e9action%20%5Cu00e0%20la%20tuberculine%20et%20une%20mise%20en%20culture%20des%20pr%5Cu00e9l%5Cu00e8vements%20microbiologiques.%5CnR%5Cu00e9sultats%5CnLa%20tuberculose%20a%20%5Cu00e9t%5Cu00e9%20diagnostiqu%5Cu00e9e%20chez%2057%20%2823%5Cu00a0%25%29%20patients%5Cu00a0%3A%20pulmonaire%20chez%2023%20%2840%5Cu00a0%25%29%2C%20extrapulmonaire%20chez%2016%20%2828%5Cu00a0%25%29%2C%20et%20diss%5Cu00e9min%5Cu00e9e%20chez%2018%20%2832%5Cu00a0%25%29%20patients.%20Dix-sept%20%2830%5Cu00a0%25%29%20%5Cu00e9taient%20immunod%5Cu00e9prim%5Cu00e9s%2C%20dont%2012%5Cu00a0%5Cu00e9taient%20infect%5Cu00e9s%20par%20le%20VIH.%20La%20sensibilit%5Cu00e9%20du%20QFN%20%5Cu00e9tait%20de%2074%5Cu00a0%25%2C%20la%20sp%5Cu00e9cificit%5Cu00e9%20de%2056%5Cu00a0%25%2C%20la%20valeur%20pr%5Cu00e9dictive%20positive%20de%2043%5Cu00a0%25%20et%20la%20valeur%20pr%5Cu00e9dictive%20n%5Cu00e9gative%20de%2092%5Cu00a0%25.%20La%20sensibilit%5Cu00e9%20%5Cu00e9tait%20similaire%20dans%20les%20tuberculoses%20pulmonaires%20et%20extrapulmonaires%20mais%20diminu%5Cu00e9e%2C%20non%20significativement%2C%20dans%20les%20tuberculoses%20diss%5Cu00e9min%5Cu00e9es.%20La%20sensibilit%5Cu00e9%20%5Cu00e9tait%20diminu%5Cu00e9e%20%28p%3D0%2C04%29%20chez%20les%20patients%20immunod%5Cu00e9prim%5Cu00e9s.%20La%20sp%5Cu00e9cificit%5Cu00e9%20du%20QFN%20chez%20les%20migrants%20%5Cu00e9tait%20inf%5Cu00e9rieure%20%5Cu00e0%20celle%20chez%20les%20patients%20n%5Cu00e9s%20en%20France%20%28p%3D0%2C01%29.%20Chez%20ceux%20avec%20ant%5Cu00e9c%5Cu00e9dents%20de%20tuberculose%2C%20elle%20%5Cu00e9tait%20inf%5Cu00e9rieure%20%5Cu00e0%20celle%20chez%20ceux%20sans%20ant%5Cu00e9c%5Cu00e9dent%20%28p%3C0%2C001%29.%20Enfin%2C%20la%20combinaison%20de%20la%20culture%20et%20du%20QFN%20augmentait%20significativement%20la%20sensibilit%5Cu00e9%20%28p%3D0%2C008%29%2C%20ainsi%20que%20la%20valeur%20pr%5Cu00e9dictive%20n%5Cu00e9gative%5Cu00a0%3B%20il%20en%20%5Cu00e9tait%20de%20m%5Cu00eame%20pour%20la%20combinaison%20avec%20l%5Cu2019intradermor%5Cu00e9action%2C%20mais%20de%20fa%5Cu00e7on%20non%20significative%20par%20rapport%20%5Cu00e0%20celle%20du%20QFN%20seul.%5CnConclusion%5CnLa%20performance%20du%20QFN%20%5Cu00e9tait%20faible%20dans%20ce%20contexte%2C%20particuli%5Cu00e8rement%20dans%20les%20sous-groupes%20%5Cu00e0%20haut%20risque%20de%20tuberculose%20latente.%20N%5Cu00e9anmoins%2C%20la%20combinaison%20de%20r%5Cu00e9sultats%20n%5Cu00e9gatifs%20du%20QFN%20ou%20de%20l%5Cu2019intradermor%5Cu00e9action%20et%20de%20la%20culture%2C%20pourrait%20%5Cu00eatre%20utile%20pour%20%5Cu00e9liminer%20une%20tuberculose%20active.%22%2C%22date%22%3A%222012-12-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.medmal.2012.08.003%22%2C%22ISSN%22%3A%220399-077X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0399077X12002053%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-04-02T21%3A31%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22QFCEGFUJ%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nessar%20et%20al.%22%2C%22parsedDate%22%3A%222012-04-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENessar%2C%20R.%2C%20Cambau%2C%20E.%2C%20Reyrat%2C%20J.%20M.%2C%20Murray%2C%20A.%20and%20Gicquel%2C%20B.%20%282012%29.%20%3Cb%3EMycobacterium%20abscessus%3A%20a%20new%20antibiotic%20nightmare%3C%5C%2Fb%3E.%20J%20Antimicrob%20Chemother%20%3Ci%3E67%3C%5C%2Fi%3E%2C%20810%26%23x2013%3B818%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkr578%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkr578%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mycobacterium%20abscessus%3A%20a%20new%20antibiotic%20nightmare%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachid%22%2C%22lastName%22%3A%22Nessar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20Marc%22%2C%22lastName%22%3A%22Reyrat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alan%22%2C%22lastName%22%3A%22Murray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brigitte%22%2C%22lastName%22%3A%22Gicquel%22%7D%5D%2C%22abstractNote%22%3A%22The%20intrinsic%20and%20acquired%20resistance%20of%20Mycobacterium%20abscessus%20to%20commonly%20used%20antibiotics%20limits%20the%20chemotherapeutic%20options%20for%20infections%20caused%20by%20these%20mycobacteria.%20Intrinsic%20resistance%20is%20attributed%20to%20a%20combination%20of%20the%20permeability%20barrier%20of%20the%20complex%20multilayer%20cell%20envelope%2C%20drug%20export%20systems%2C%20antibiotic%20targets%20with%20low%20affinity%20and%20enzymes%20that%20neutralize%20antibiotics%20in%20the%20cytoplasm.%20To%20date%2C%20acquired%20resistance%20has%20only%20been%20observed%20for%20aminoglycosides%20and%20macrolides%2C%20which%20is%20conferred%20by%20mutations%20affecting%20the%20genes%20encoding%20the%20antibiotic%20targets%20%28rrs%20and%20rrl%2C%20respectively%29.%20Here%20we%20summarize%20previous%20and%20recent%20findings%20on%20the%20resistance%20of%20M.%20abscessus%20to%20antibiotics%20in%20light%20of%20what%20has%20been%20discovered%20for%20other%20mycobacteria.%20Since%20we%20can%20now%20distinguish%20three%20groups%20of%20strains%20belonging%20to%20M.%20abscessus%20%28M.%20abscessus%20sensu%20stricto%2C%20Mycobacterium%20massiliense%20and%20Mycobacterium%20bolletii%29%2C%20studies%20on%20antibiotic%20susceptibility%20and%20resistance%20should%20be%20considered%20according%20to%20this%20new%20classification.%20This%20review%20raises%20the%20profile%20of%20this%20important%20pathogen%20and%20highlights%20the%20work%20needed%20to%20decipher%20the%20molecular%20events%20responsible%20for%20its%20extensive%20chemotherapeutic%20resistance.%22%2C%22date%22%3A%2204%5C%2F01%5C%2F2012%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1093%5C%2Fjac%5C%2Fdkr578%22%2C%22ISSN%22%3A%220305-7453%2C%201460-2091%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjac.oxfordjournals.org%5C%2Fcontent%5C%2F67%5C%2F4%5C%2F810%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A52%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22JT79M536%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pantel%20et%20al.%22%2C%22parsedDate%22%3A%222012-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPantel%2C%20A.%2C%20Petrella%2C%20S.%2C%20Veziris%2C%20N.%2C%20Brossier%2C%20F.%2C%20Bastian%2C%20S.%2C%20Jarlier%2C%20V.%2C%20Mayer%2C%20C.%20and%20Aubry%2C%20A.%20%282012%29.%20%3Cb%3EExtending%20the%20Definition%20of%20the%20GyrB%20Quinolone%20Resistance-Determining%20Region%20in%20Mycobacterium%20tuberculosis%20DNA%20Gyrase%20for%20Assessing%20Fluoroquinolone%20Resistance%20in%20M.%20tuberculosis%3C%5C%2Fb%3E.%20Antimicrob%20Agents%20Chemother%20%3Ci%3E56%3C%5C%2Fi%3E%2C%201990%26%23x2013%3B1996%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.06272-11%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.06272-11%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Extending%20the%20Definition%20of%20the%20GyrB%20Quinolone%20Resistance-Determining%20Region%20in%20Mycobacterium%20tuberculosis%20DNA%20Gyrase%20for%20Assessing%20Fluoroquinolone%20Resistance%20in%20M.%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alix%22%2C%22lastName%22%3A%22Pantel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22Petrella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvaine%22%2C%22lastName%22%3A%22Bastian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudine%22%2C%22lastName%22%3A%22Mayer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22Fluoroquinolone%20%28FQ%29%20resistance%20is%20emerging%20in%20Mycobacterium%20tuberculosis.%20The%20main%20mechanism%20of%20FQ%20resistance%20is%20amino%20acid%20substitution%20within%20the%20quinolone%20resistance-determining%20region%20%28QRDR%29%20of%20the%20GyrA%20subunit%20of%20DNA%20gyrase%2C%20the%20sole%20FQ%20target%20in%20M.%20tuberculosis.%20However%2C%20substitutions%20in%20GyrB%20whose%20implication%20in%20FQ%20resistance%20is%20unknown%20are%20increasingly%20being%20reported.%20The%20present%20study%20clarified%20the%20role%20of%20four%20GyrB%20substitutions%20identified%20in%20M.%20tuberculosis%20clinical%20strains%2C%20two%20located%20in%20the%20QRDR%20%28D500A%20and%20N538T%29%20and%20two%20outside%20the%20QRDR%20%28T539P%20and%20E540V%29%2C%20in%20FQ%20resistance.%20We%20measured%20FQ%20MICs%20and%20also%20DNA%20gyrase%20inhibition%20by%20FQs%20in%20order%20to%20unequivocally%20clarify%20the%20role%20of%20these%20mutations%20in%20FQ%20resistance.%20Wild-type%20GyrA%2C%20wild-type%20GyrB%2C%20and%20mutant%20GyrB%20subunits%20produced%20from%20engineered%20gyrB%20alleles%20by%20mutagenesis%20were%20overexpressed%20in%20Escherichia%20coli%2C%20purified%20to%20homogeneity%2C%20and%20used%20to%20reconstitute%20highly%20active%20gyrase%20complexes.%20MICs%20and%20DNA%20gyrase%20inhibition%20were%20determined%20for%20moxifloxacin%2C%20gatifloxacin%2C%20ofloxacin%2C%20levofloxacin%2C%20and%20enoxacin.%20All%20these%20substitutions%20are%20clearly%20implicated%20in%20FQ%20resistance%2C%20underlining%20the%20presence%20of%20a%20hot%20spot%20region%20housing%20most%20of%20the%20GyrB%20substitutions%20implicated%20in%20FQ%20resistance%20%28residues%20NTE%2C%20538%20to%20540%29.%20These%20findings%20help%20us%20to%20refine%20the%20definition%20of%20GyrB%20QRDR%2C%20which%20is%20extended%20to%20positions%20500%20to%20540.%22%2C%22date%22%3A%222012-4%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.06272-11%22%2C%22ISSN%22%3A%220066-4804%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3318379%5C%2F%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A54%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22UQA4EI2T%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ruf%20et%20al.%22%2C%22parsedDate%22%3A%222012-02-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ERuf%2C%20M.-T.%2C%20Sch%26%23xFC%3Btte%2C%20D.%2C%20Chauffour%2C%20A.%2C%20Jarlier%2C%20V.%2C%20Ji%2C%20B.%20and%20Pluschke%2C%20G.%20%282012%29.%20%3Cb%3EChemotherapy-Associated%20Changes%20of%20Histopathological%20Features%20of%20Mycobacterium%20ulcerans%20Lesions%20in%20a%20Buruli%20Ulcer%20Mouse%20Model%3C%5C%2Fb%3E.%20Antimicrob%20Agents%20Chemother%20%3Ci%3E56%3C%5C%2Fi%3E%2C%20687%26%23x2013%3B696%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.05543-11%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.05543-11%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Chemotherapy-Associated%20Changes%20of%20Histopathological%20Features%20of%20Mycobacterium%20ulcerans%20Lesions%20in%20a%20Buruli%20Ulcer%20Mouse%20Model%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Th%5Cu00e9r%5Cu00e8se%22%2C%22lastName%22%3A%22Ruf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22Sch%5Cu00fctte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Baohong%22%2C%22lastName%22%3A%22Ji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerd%22%2C%22lastName%22%3A%22Pluschke%22%7D%5D%2C%22abstractNote%22%3A%22Combination%20chemotherapy%20with%20rifampin%20and%20streptomycin%20%28RIF-STR%29%20for%208%20weeks%20is%20currently%20recommended%20by%20the%20WHO%20as%20the%20first-line%20treatment%20for%20Mycobacterium%20ulcerans%20infection%20%28Buruli%20ulcer%29.%20To%20gain%20better%20insight%20into%20the%20mode%20of%20action%20of%20these%20antibiotics%20against%20established%20M.%20ulcerans%20infection%20foci%20and%20to%20characterize%20recovery%20of%20local%20immune%20responses%20during%20chemotherapy%2C%20we%20conducted%20a%20detailed%20histopathological%20study%20of%20M.%20ulcerans-infected%20and%20RIF-STR-treated%20mice.%20Mice%20were%20inoculated%20with%20M.%20ulcerans%20in%20the%20footpad%20and%2011%20weeks%20later%20treated%20with%20RIF-STR.%20Development%20of%20lesions%20during%20the%20first%2011%20weeks%20after%20infection%20and%20subsequent%20differences%20in%20disease%20progression%20between%20RIF-STR-treated%20and%20untreated%20mice%20were%20studied.%20Changes%20in%20histopathological%20features%2C%20footpad%20swelling%2C%20and%20number%20of%20CFU%20were%20analyzed.%20After%20inoculation%20with%20M.%20ulcerans%2C%20massive%20infiltrates%20dominated%20by%20polymorphonuclear%20leukocytes%20developed%20at%20the%20inoculation%20site%20but%20did%20not%20prevent%20bacterial%20multiplication.%20Huge%20clusters%20of%20extracellular%20bacteria%20located%20in%20large%20necrotic%20areas%20and%20surrounded%20by%20dead%20leukocytes%20developed%20in%20the%20untreated%20mice.%20Chemotherapy%20with%20RIF-STR%20led%20to%20a%20rapid%20drop%20in%20CFU%20associated%20with%20loss%20of%20solid%20Ziehl-Neelsen%20staining%20of%20acid-fast%20bacilli.%20Development%20of%20B-lymphocyte%20clusters%20and%20of%20macrophage%20accumulations%20surrounding%20the%20mycobacteria%20demonstrated%20the%20resolution%20of%20local%20immune%20suppression.%20Results%20demonstrate%20that%20the%20experimental%20M.%20ulcerans%20mouse%20infection%20model%20will%20be%20a%20valuable%20tool%20to%20investigate%20efficacy%20of%20new%20treatment%20regimens%20and%20of%20candidate%20vaccines.%22%2C%22date%22%3A%2202%5C%2F01%5C%2F2012%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.05543-11%22%2C%22ISSN%22%3A%220066-4804%2C%201098-6596%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Faac.asm.org%5C%2Fcontent%5C%2F56%5C%2F2%5C%2F687%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-27T14%3A02%3A26Z%22%7D%7D%2C%7B%22key%22%3A%225DF8XIME%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Segala%20et%20al.%22%2C%22parsedDate%22%3A%222012-05-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESegala%2C%20E.%2C%20Sougakoff%2C%20W.%2C%20Nevejans-Chauffour%2C%20A.%2C%20Jarlier%2C%20V.%20and%20Petrella%2C%20S.%20%282012%29.%20%3Cb%3ENew%20Mutations%20in%20the%20Mycobacterial%20ATP%20Synthase%3A%20New%20Insights%20into%20the%20Binding%20of%20the%20Diarylquinoline%20TMC207%20to%20the%20ATP%20Synthase%20C-Ring%20Structure%3C%5C%2Fb%3E.%20Antimicrob%20Agents%20Chemother%20%3Ci%3E56%3C%5C%2Fi%3E%2C%202326%26%23x2013%3B2334%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.06154-11%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.06154-11%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22New%20Mutations%20in%20the%20Mycobacterial%20ATP%20Synthase%3A%20New%20Insights%20into%20the%20Binding%20of%20the%20Diarylquinoline%20TMC207%20to%20the%20ATP%20Synthase%20C-Ring%20Structure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elena%22%2C%22lastName%22%3A%22Segala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aurelie%22%2C%22lastName%22%3A%22Nevejans-Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22Petrella%22%7D%5D%2C%22abstractNote%22%3A%22TMC207%20is%20a%20new%20antituberculous%20drug%20belonging%20to%20the%20diarylquinoline%20class%20which%20very%20efficiently%20inhibits%20the%20ATP%20synthase%20of%20mycobacteria%20such%20as%20Mycobacterium%20tuberculosis%2C%20one%20of%20the%20most%20important%20pathogens%20in%20the%20world.%20In%20order%20to%20map%20the%20amino%20acid%20residues%20involved%20in%20the%20binding%20of%20the%20drug%2C%20we%20have%20selected%20in%20vitro%20TMC207-resistant%20mutants%20from%20M.%20tuberculosis%20and%20diverse%20atypical%20mycobacteria.%20Six%20distinct%20mutations%2C%20Asp28%5Cu2192Gly%2C%20Asp28%5Cu2192Ala%2C%20Leu59%5Cu2192Val%2C%20Glu61%5Cu2192Asp%2C%20Ala63%5Cu2192Pro%2C%20and%20Ile66%5Cu2192Met%2C%20have%20been%20identified%20in%20the%20subunit%20c%20forming%20a%20C%20ring%20in%20the%20ATP%20synthase.%20They%20were%20studied%20by%20evaluating%20the%20levels%20of%20resistance%20that%20they%20confer%20in%20the%20selected%20clones%20and%20by%20using%20an%20isogenic%20complementation%20system%20in%20Mycobacterium%20smegmatis.%20The%20rates%20of%20increase%20of%20TMC207%20MIC%20values%20%288-%20to%20133-fold%29%20were%20interpreted%20by%20constructing%20by%20homology%20modeling%20a%20structure%20of%20the%20mycobacterial%20C%20ring%20which%20was%20used%20for%20docking%20simulations%20with%20TMC207.%20Our%20results%20suggest%20that%20the%20residues%20found%20to%20be%20mutated%20in%20the%20resistant%20clones%2C%20together%20with%20a%20tyrosine%20specifically%20conserved%20at%20position%2064%20in%20mycobacteria%2C%20define%20a%20cleft%20located%20between%20two%20adjacent%20c%20subunits%20in%20the%20C%20ring.%20This%20cleft%2C%20which%20encompasses%20the%20proton-binding%20site%20%28Glu61%29%2C%20is%20well%20fitted%20to%20bind%20TMC207%20at%20the%20level%20of%20the%20bromoquinoline%20moiety%2C%20with%20the%20drug%20being%20anchored%20by%20several%20ionic%2C%20hydrogen%2C%20and%20halogen%20bonds%20with%20residues%20Glu61%2C%20Tyr64%2C%20and%20Asp28%2C%20respectively.%20These%20data%20shed%20light%20on%20the%20molecular%20interactions%20allowing%20TMC207%20to%20bind%20specifically%20and%20efficiently%20at%20the%20level%20of%20the%20proton-binding%20site%20of%20the%20mycobacterial%20C%20ring.%22%2C%22date%22%3A%2205%5C%2F01%5C%2F2012%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.06154-11%22%2C%22ISSN%22%3A%220066-4804%2C%201098-6596%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Faac.asm.org%5C%2Fcontent%5C%2F56%5C%2F5%5C%2F2326%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-25T16%3A02%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22WCGP6AHS%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Valade%20et%20al.%22%2C%22parsedDate%22%3A%222012%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EValade%2C%20S.%2C%20Raskine%2C%20L.%2C%20Aout%2C%20M.%2C%20Malissin%2C%20I.%2C%20Brun%2C%20P.%2C%20Deye%2C%20N.%2C%20Baud%2C%20F.%20J.%20and%20Megarbane%2C%20B.%20%282012%29.%20%3Cb%3ETuberculosis%20in%20the%20intensive%20care%20unit%3A%20A%20retrospective%20descriptive%20cohort%20study%20with%20determination%20of%20a%20predictive%20fatality%20score%3C%5C%2Fb%3E.%20Can%20J%20Infect%20Dis%20Med%20Microbiol%20%3Ci%3E23%3C%5C%2Fi%3E%2C%20173%26%23x2013%3B178%2C%20URL%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3597393%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3597393%5C%2F%3C%5C%2Fa%3E%20%5BAccessed%20July%202014%5D.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tuberculosis%20in%20the%20intensive%20care%20unit%3A%20A%20retrospective%20descriptive%20cohort%20study%20with%20determination%20of%20a%20predictive%20fatality%20score%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandrine%22%2C%22lastName%22%3A%22Valade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mounir%22%2C%22lastName%22%3A%22Aout%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Malissin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Brun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Deye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederic%20J%22%2C%22lastName%22%3A%22Baud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%22%2C%22lastName%22%3A%22Megarbane%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%5CnDespite%20effective%20treatments%2C%20tuberculosis-related%20mortality%20remains%20high%20among%20patients%20requiring%20admission%20to%20the%20intensive%20care%20unit%20%28ICU%29.%5Cn%5CnOBJECTIVE%3A%5CnTo%20determine%20prognostic%20factors%20of%20death%20in%20tuberculosis%20patients%20admitted%20to%20the%20ICU%2C%20and%20to%20develop%20a%20simple%20predictive%20scoring%20system.%5Cn%5CnMETHODS%3A%5CnA%2010-year%2C%20retrospective%20study%20of%2053%20patients%20admitted%20consecutively%20to%20the%20H%5Cu00f4pitaux%20de%20Paris%2C%20H%5Cu00f4pital%20Lariboisi%5Cu00e8re%20%28Paris%2C%20France%29%20ICU%20with%20confirmed%20tuberculosis%2C%20was%20conducted.%20A%20multivariate%20analysis%20was%20performed%20to%20identify%20risk%20factors%20for%20death.%20A%20predictive%20fatality%20score%20was%20determined.%5Cn%5CnRESULTS%3A%5CnDiagnoses%20included%20pulmonary%20tuberculosis%20%2896%25%29%20and%20tuberculous%20encephalomeningitis%20%2826%25%29.%20Patients%20required%20mechanical%20ventilation%20%2845%25%29%20and%20vasopressor%20infusion%20%2828%25%29%20on%20admission.%20Twenty%20patients%20%2838%25%29%20died%2C%20related%20to%20direct%20tuberculosis-induced%20organ%20failure%20%28n%3D5%29%2C%20pulmonary%20bacterial%20coinfections%20%28n%3D14%29%20and%20pulmonary%20embolism%20%28n%3D1%29.%20Using%20a%20multivariate%20analysis%2C%20three%20independent%20factors%20on%20ICU%20admission%20were%20predictive%20of%20fatality%3A%20miliary%20pulmonary%20tuberculosis%20%28OR%209.04%20%5B95%25%20CI%201.25%20to%2065.30%5D%29%2C%20mechanical%20ventilation%20%28OR%2011.36%20%5B95%25%20CI%201.55%20to%2083.48%5D%29%20and%20vasopressor%20requirement%20%28OR%208.45%20%5B95%25%20CI%201.29%20to%2055.18%5D%29.%20A%20score%20generated%20by%20summing%20these%20three%20independent%20variables%20was%20effective%20at%20predicting%20fatality%20with%20an%20area%20under%20the%20ROC%20curve%20of%200.92%20%2895%25%20CI%200.85%20to%200.98%29.%5Cn%5CnCONCLUSIONS%3A%5CnFatalities%20remain%20high%20in%20patients%20admitted%20to%20the%20ICU%20with%20tuberculosis.%20Miliary%20pulmonary%20tuberculosis%2C%20mechanical%20ventilation%20and%20vasopressor%20requirement%20on%20admission%20were%20predictive%20of%20death.%22%2C%22date%22%3A%222012%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221712-9532%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3597393%5C%2F%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A56%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22B95WE7FI%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Veziris%22%2C%22parsedDate%22%3A%222012-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EVeziris%2C%20N.%20%282012%29.%20%3Cb%3EDiagnostic%20bact%26%23xE9%3Briologique%20de%20la%20tuberculose%3C%5C%2Fb%3E.%20Rev%20Prat%20%3Ci%3E62%3C%5C%2Fi%3E%2C%20490%26%23x2013%3B492.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Diagnostic%20bact%5Cu00e9riologique%20de%20la%20tuberculose%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22Today%2C%20microscopic%20examination%20and%20culture%20are%20still%20essential%20for%20active%20tuberculosis%20diagnosis%20and%20therapeutic%20decisions.%20Nucleic%20acid%20amplification%20and%20line%20probe%20assays%20speed%20up%20identification%20and%20susceptibility%20testing%20of%20mycobacteria%20in%20AFB%20smear%20positive%20specimens%20or%20in%20culture.%20They%20are%20also%20efficient%20for%20comparison%20of%20M.%20tuberculosis%20strains%20with%20each%20other%20%28genotyping%29.%20On%20the%20other%20hand%2C%20today%2C%20molecular%20tests%20are%20not%20relevant%20for%20the%20diagnosis%20in%20smear%20negative%20specimens%20and%20even%20more%20for%20diagnosis%20of%20culture-negative%20tuberculosis.%22%2C%22date%22%3A%22Apr%202012%22%2C%22language%22%3A%22fre%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%220035-2640%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A53%3A53Z%22%7D%7D%2C%7B%22key%22%3A%2237R647CZ%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Veziris%20et%20al.%22%2C%22parsedDate%22%3A%222012%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EVeziris%2C%20N.%2C%20Aubry%2C%20A.%2C%20Robert%2C%20J.%2C%20Cambau%2C%20E.%2C%20Jarlier%2C%20V.%20and%20Truffot-Pernot%2C%20C.%20%282012%29.%20%3Cb%3EMycobacte%26%23x301%3Bries%3C%5C%2Fb%3E.%20In%3A%20%3Cb%3EAntibiogramme%3C%5C%2Fb%3E%2C%20ESKA%2C%20pp.%20663%26%23x2013%3B687.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Mycobacte%5Cu0301ries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Truffot-Pernot%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22bookTitle%22%3A%22Antibiogramme%22%2C%22date%22%3A%222012%22%2C%22language%22%3A%22%22%2C%22ISBN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-25T16%3A12%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22AJHEC73Q%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Veziris%20et%20al.%22%2C%22parsedDate%22%3A%222012%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EVeziris%2C%20N.%2C%20Jarlier%2C%20V.%20and%20Robert%2C%20J.%20%282012%29.%20%3Cb%3ELa%20r%26%23xE9%3Bsistance%20aux%20antituberculeux%20en%20France%20en%202009-2010%3C%5C%2Fb%3E.%20BEH%20%3Ci%3E24%26%23x2013%3B25%3C%5C%2Fi%3E%2C%20291%26%23x2013%3B293%2C%20URL%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fopac.invs.sante.fr%5C%2Fdoc_num.php%3Fexplnum_id%3D8241%27%3Ehttp%3A%5C%2F%5C%2Fopac.invs.sante.fr%5C%2Fdoc_num.php%3Fexplnum_id%3D8241%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22La%20r%5Cu00e9sistance%20aux%20antituberculeux%20en%20France%20en%202009-2010%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%22%2C%22lastName%22%3A%22Robert%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222012%22%2C%22language%22%3A%22fr%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fopac.invs.sante.fr%5C%2Fdoc_num.php%3Fexplnum_id%3D8241%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-25T16%3A17%3A15Z%22%7D%7D%5D%7D
Ahuja, S. D., Ashkin, D., Avendano, M., Banerjee, R., Bauer, M., Bayona, J. N., Becerra, M. C., Benedetti, A., Burgos, M., Centis, R., Chan, E. D., Chiang, C.-Y., Cox, H., D’Ambrosio, L., DeRiemer, K., Dung, N. H., Enarson, D., Falzon, D., Flanagan, K., Flood, J., Garcia-Garcia, M. L., Gandhi, N., Granich, R. M., Hollm-Delgado, M. G., Holtz, T. H., Iseman, M. D., Jarlsberg, L. G., Keshavjee, S., Kim, H.-R., Koh, W.-J., Lancaster, J., Lange, C., Lange, W. C. M. de, Leimane, V., Leung, C. C., Li, J., Menzies, D., Migliori, G. B., Mishustin, S. P., Mitnick, C. D., Narita, M., O’Riordan, P., Pai, M., Palmero, D., Park, S., Pasvol, G., Peña, J., Pérez-Guzmán, C., Quelapio, M. I. D., Ponce-de-Leon, A., Riekstina, V., Robert, J., Royce, S., Schaaf, H. S., Seung, K. J., Shah, L., Shim, T. S., Shin, S. S., Shiraishi, Y., Sifuentes-Osornio, J., Sotgiu, G., Strand, M. J., Tabarsi, P., Tupasi, T. E., Altena, R. van, Walt, M. V. der, Werf, T. S. V. der, Vargas, M. H., Viiklepp, P., Westenhouse, J., Yew, W. W. and Yim, J.-J. (2012). Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients. PLOS Med 9, e1001300, http://doi.org/10.1371/journal.pmed.1001300.
Andréjak, C., Veziris, N., Lescure, X., Cadranel, J. and Jounieaux, V. (2012). Essai CaMoMy : évaluation de la capacité de deux schémas thérapeutiques (Clarithromycine ou Moxifloxacine) à négativer les cultures à six mois de malades porteurs d’une infection pulmonaire à Mycobacterium xenopi. PHRC national 2010. Revue des Maladies Respiratoires 29, Supplement 1, A25, http://doi.org/10.1016/j.rmr.2011.10.030.
Bernard, C., Sougakoff, W., Fournier, A., Larnaudie, S., Antoun, F., Robert, J., Brossier, F., Truffot-Pernot, C., Jarlier, V. and Veziris, N. (2012). Impact of a 14-year screening programme on tuberculosis transmission among the homeless in Paris. Int J Tuberc Lung Dis 16, 649–655, http://doi.org/10.5588/ijtld.11.0241.
Broutin, V., Bañuls, A.-L., Aubry, A., Keck, N., Choisy, M., Bernardet, J.-F., Michel, C., Raymond, J.-C., Libert, C., Barnaud, A., Stragier, P., Portaels, F., Terru, D., Belon, C., Dereure, O., Gutierrez, C., Boschiroli, M.-L., Perre, P. V. D., Cambau, E. and Godreuil, S. (2012). Genetic Diversity and Population Structure of Mycobacterium marinum: New Insights into Host and Environmental Specificities. J Clin Microbiol 50, 3627–3634, http://doi.org/10.1128/JCM.01274-12.
Bussone, G., Brossier, F., Roudiere, L., Bille, E., Sekkal, N., Charlier, C., Gilquin, J., Lanternier, F., Lecuit, M., Lortholary, O. and Catherinot, E. (2012). Recurrent Mycobacterium avium infection after seven years of latency in a HIV-infected patient receiving efficient antiretroviral therapy. Journal of Infection 64, 613–617, http://doi.org/10.1016/j.jinf.2011.12.020.
Cambau, E., Chauffour-Nevejans, A., Tejmar-Kolar, L., Matsuoka, M. and Jarlier, V. (2012). Detection of Antibiotic Resistance in Leprosy Using GenoType LepraeDR, a Novel Ready-To-Use Molecular Test. PLoS Negl Trop Dis 6, e1739, http://doi.org/10.1371/journal.pntd.0001739.
Cosson, M.-A., Bertrand, J.-B., Martin, C., Veziris, N., Picard, C., Goulvestre, C., Coignard, S., Benoit, J.-P., Silvera, S., Moro, M.-R., Poyart, C. and Morand, P. C. (2012). Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient. J Med Microbiol 61, 1617–1620, http://doi.org/10.1099/jmm.0.042739-0.
Darmon, A., Piton, J., Roué, M., Petrella, S., Aubry, A. and Mayer, C. (2012). Purification, crystallization and preliminary X-ray crystallographic studies of the Mycobacterium tuberculosis DNA gyrase CTD. Acta Crystallogr Sect F Struct Biol Cryst Commun 68, 178–180, http://doi.org/10.1107/S1744309111051888.
de Beer, J. L., Kremer, K., Ködmön, C., Supply, P., Soolingen, D. van and 2009, the G. N. for the M. S. of T. (2012). First Worldwide Proficiency Study on Variable-Number Tandem-Repeat Typing of Mycobacterium tuberculosis Complex Strains. J Clin Microbiol 50, 662–669, http://doi.org/10.1128/JCM.00607-11.
Dutilh, J., Caron, F., Bourgoin, A., Veziris, N. and Meurice, J.-C. (2012). Un cas atypique de mycobactérie. Revue des Maladies Respiratoires 29, 1182, http://doi.org/10.1016/j.rmr.2012.10.014.
Fillion, A. and Veziris, N. (2012). Évaluation de l’efficacité de la moxifloxacine dans le traitement des tuberculoses à bacilles résistants à l’ofloxacine. Revue des Maladies Respiratoires 29, Supplement 1, A12, http://doi.org/10.1016/j.rmr.2011.10.961.
Laboratoire de bactériologie et d’hygiène, hôpital la Pitié-Salpêtrière, AP-HP, FRA, CNR des mycobactéries et de la résistance des mycobactéries aux antituberculeux, FRA, Laboratoire de bactériologie et d’hygiène, EA 1541/ER5, université Pierre-et-Marie-Curie, FRA, Ces 2 auteurs ont contribué à part égale à la rédaction du manuscrit, FRA, A, F., A, P., N, V. and A, A. (2012). Place des fluoroquinolones dans le traitement des tuberculoses à bacilles résistants : La tuberculose en 2012. La Lettre du pneumologue 15, 12–16, URL: http://www.refdoc.fr/Detailnotice?idarticle.
Legout, L., Ettahar, N., Massongo, M., Veziris, N., Ajana, F., Beltrand, E. and Senneville, E. (2012). Osteomyelitis of the wrist caused by Mycobacterium arupense in an immunocompetent patient: a unique case. Int J Infect Dis 16, e761-762, http://doi.org/10.1016/j.ijid.2012.05.007.
Lhuillier, E., Brugière, O., Veziris, N., Danel, C., Mourvilliers, B., Mal, H., Dauriat, G. and Ruimy, R. (2012). Relapsing Mycobacterium genavense infection as a cause of late death in a lung transplant recipient: case report and review of the literature. Exp Clin Transplant 10, 618–620, http://doi.org/10.6002/ect.2012.0052.
Maruri, F., Sterling, T. R., Kaiga, A. W., Blackman, A., Heijden, Y. F. van der, Mayer, C., Cambau, E. and Aubry, A. (2012). A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. J Antimicrob Chemother 67, 819–831, http://doi.org/10.1093/jac/dkr566.
Meyssonnier, V., Veziris, N., Bastian, S., Texier-Maugein, J., Jarlier, V. and Robert, J. (2012). Increase in primary drug resistance of Mycobacterium tuberculosis in younger birth cohorts in France. Journal of Infection 64, 589–595, http://doi.org/10.1016/j.jinf.2012.01.013.
Meyssonnier, V., Guihot, A., Chevet, K., Veziris, N., Assoumou, L., Bourgarit, A., Costagliola, D., Caumes, E. and Carcelin, G. (2012). Performance of Quantiferon® for the diagnosis TB. Médecine et Maladies Infectieuses 42, 579–584, http://doi.org/10.1016/j.medmal.2012.08.003.
Nessar, R., Cambau, E., Reyrat, J. M., Murray, A. and Gicquel, B. (2012). Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother 67, 810–818, http://doi.org/10.1093/jac/dkr578.
Pantel, A., Petrella, S., Veziris, N., Brossier, F., Bastian, S., Jarlier, V., Mayer, C. and Aubry, A. (2012). Extending the Definition of the GyrB Quinolone Resistance-Determining Region in Mycobacterium tuberculosis DNA Gyrase for Assessing Fluoroquinolone Resistance in M. tuberculosis. Antimicrob Agents Chemother 56, 1990–1996, http://doi.org/10.1128/AAC.06272-11.
Ruf, M.-T., Schütte, D., Chauffour, A., Jarlier, V., Ji, B. and Pluschke, G. (2012). Chemotherapy-Associated Changes of Histopathological Features of Mycobacterium ulcerans Lesions in a Buruli Ulcer Mouse Model. Antimicrob Agents Chemother 56, 687–696, http://doi.org/10.1128/AAC.05543-11.
Segala, E., Sougakoff, W., Nevejans-Chauffour, A., Jarlier, V. and Petrella, S. (2012). New Mutations in the Mycobacterial ATP Synthase: New Insights into the Binding of the Diarylquinoline TMC207 to the ATP Synthase C-Ring Structure. Antimicrob Agents Chemother 56, 2326–2334, http://doi.org/10.1128/AAC.06154-11.
Valade, S., Raskine, L., Aout, M., Malissin, I., Brun, P., Deye, N., Baud, F. J. and Megarbane, B. (2012). Tuberculosis in the intensive care unit: A retrospective descriptive cohort study with determination of a predictive fatality score. Can J Infect Dis Med Microbiol 23, 173–178, URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597393/ [Accessed July 2014].
Veziris, N. (2012). Diagnostic bactériologique de la tuberculose. Rev Prat 62, 490–492.
Veziris, N., Aubry, A., Robert, J., Cambau, E., Jarlier, V. and Truffot-Pernot, C. (2012). Mycobactéries. In: Antibiogramme, ESKA, pp. 663–687.
Veziris, N., Jarlier, V. and Robert, J. (2012). La résistance aux antituberculeux en France en 2009-2010. BEH 24–25, 291–293, URL: http://opac.invs.sante.fr/doc_num.php?explnum_id=8241.